Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy

Author： Ström Cecilia E.   Helleday Thomas  

Publisher： MDPI

E-ISSN： 2218-273x|2|4|635-649

ISSN： 2218-273x

Source： Biomolecules, Vol.2, Iss.4, 2012-12, pp. : 635-649

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis

By Jiang Bo-Hua   Tseng Wei-Lien   Li Hsin-Yang   Wang Mong-Lien   Chang Yuh-Lih   Sung Yen-Jen   Chiou Shih-Hwa  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 15531-15545

MDPI

Access to resources Recommend Favorite

Inhibition of Poly(ADP-Ribose) Polymerase Enhances Radiochemosensitivity in Cancers Proficient in DNA Double-Strand Break Repair

By Shunkwiler Lauren   Ferris Gina   Kunos Charles  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3773-3785

MDPI

Access to resources Recommend Favorite

Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy

By Iessi Elisabetta   Logozzi Mariantonia   Mizzoni Davide   Di Raimo Rossella   Supuran Claudiu T.   Fais Stefano  

Metabolites, Vol. 8, Iss. 1, 2017-12 ,pp. : 2-2

MDPI

Access to resources Recommend Favorite

Marine-Derived Angiogenesis Inhibitors for Cancer Therapy

By Wang Ying-Qing   Miao Ze-Hong  

Marine Drugs, Vol. 11, Iss. 3, 2013-03 ,pp. : 903-933

MDPI

Access to resources Recommend Favorite

Prospects for the Use of ATR Inhibitors to Treat Cancer

By Wagner Jill M.   Kaufmann Scott H.  

Pharmaceuticals, Vol. 3, Iss. 5, 2010-04 ,pp. : 1311-1334

MDPI

Access to resources Recommend Favorite